Lattice_grid_med
Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term Randomized Controlled Trials as Topic. Found 14 abstracts

Rouvinov K, Plimack ER, Zibelman M, Ghatalia P, Geynisman DM. Update on perioperative systemic therapy for urothelial carcinoma. Clinical advances in hematology & oncology : H&O. 2019 Mar;17(3):176-83.
Harshman LC, Chen YH, Liu G, Carducci MA, Jarrard D, Dreicer R, Hahn N, Garcia JA, Hussain M, Shevrin D, Eisenberger M, Kohli M, Plimack ER, Cooney M, Vogelzang NJ, Picus J, Dipaola R, Sweeney CJ. Seven-Month Prostate-Specific Antigen Is Prognostic in Metastatic Hormone-Sensitive Prostate Cancer Treated With Androgen Deprivation With or Without Docetaxel. J Clin Oncol. 2018 Feb;36(4):376-82.   PMCID: PMC5805480
Riddle DL, Jensen MP, Ang D, Slover J, Perera R, Dumenci L. Do Pain Coping and Pain Beliefs Associate With Outcome Measures Before Knee Arthroplasty in Patients Who Catastrophize About Pain? A Cross-sectional Analysis From a Randomized Clinical Trial. Clinical orthopaedics and related research. 2018 Apr;476(4):778-86.   PMCID: PMC6260056
Fakhry C, Zhang Q, Nguyen-Tan PF, Rosenthal DI, Weber RS, Lambert L, Trotti AM, Barrett WL, Thorstad WL, Jones CU, Yom SS, Wong SJ, Ridge JA, Rao SS, Bonner JA, Vigneault E, Raben D, Kudrimoti MR, Harris J, Le QT, Gillison ML. Development and Validation of Nomograms Predictive of Overall and Progression-Free Survival in Patients With Oropharyngeal Cancer. J Clin Oncol. 2017 Dec 20;35(36):4057-65.   PMCID: PMC5736236
Meyer LA, Cronin AM, Sun CC, Bixel K, Bookman MA, Cristea MC, Griggs JJ, Levenback CF, Burger RA, Mantia-Smaldone G, Matulonis UA, Niland JC, O'Malley DM, Wright AA. Use and Effectiveness of Neoadjuvant Chemotherapy for Treatment of Ovarian Cancer. J Clin Oncol. 2016 Sep 06;34(32):3854-63.   PMCID: PMC5477982
Farma JM, Kulkarni N, Hsu C. Surgical management of primary and recurrent melanoma. Surg Oncol Clin N Am. 2015 Apr;24(2):239-47.
Tomaszewski JJ, Smaldone MC, Uzzo RG, Kutikov A. Is radical nephrectomy a legitimate therapeutic option in patients with renal masses amenable to nephron-sparing surgery?. BJU international. 2015 Mar;115(3):357-63.
Adams S, Gray RJ, Demaria S, Goldstein L, Perez EA, Shulman LN, Martino S, Wang M, Jones VE, Saphner TJ, Wolff AC, Wood WC, Davidson NE, Sledge GW, Sparano JA, Badve SS. Prognostic Value of Tumor-Infiltrating Lymphocytes in Triple-Negative Breast Cancers From Two Phase III Randomized Adjuvant Breast Cancer Trials: ECOG 2197 and ECOG 1199. Journal of Clinical Oncology. 2014 Sep;32(27):2959-66.   PMCID: 4162494
Brana I, Berger R, Golan T, Haluska P, Edenfield J, Fiorica J, Stephenson J, Martin LP, Westin S, Hanjani P, Jones MB, Almhanna K, Wenham RM, Sullivan DM, Dalton WS, Gunchenko A, Cheng JD, Siu LL, Gray JE. A parallel-arm phase I trial of the humanised anti-IGF-1R antibody dalotuzumab in combination with the AKT inhibitor MK-2206, the mTOR inhibitor ridaforolimus, or the NOTCH inhibitor MK-0752, in patients with advanced solid tumours. Br J Cancer. 2014 Nov 11;111(10):1932-44.   PMCID: Pmc4229637
McCleary NJ, Dotan E, Browner I. Refining the chemotherapy approach for older patients with colon cancer. J Clin Oncol. 2014 Aug 20;32(24):2570-80.
Egleston BL. Response to Pearl's Comments on Principal Stratification. Int J Biostat. 2011 Jan;7(1):24.   PMCID: PMC3114954
Parmar MK, Barthel FM, Sydes M, Langley R, Kaplan R, Eisenhauer E, Brady M, James N, Bookman MA, Swart AM, Qian W, Royston P. Speeding up the evaluation of new agents in cancer. Journal of the National Cancer Institute. 2008 Sep 03;100(17):1204-14.   PMCID: PMC2528020
Morrow M, Goldstein L. Surgery of the primary tumor in metastatic breast cancer: closing the barn door after the horse has bolted?. J Clin Oncol. 2006 Jun 20;24(18):2694-6.
Ozols RF, Bookman MA, du Bois A, Pfisterer J, Reuss A, Young RC. Intraperitoneal cisplatin therapy in ovarian cancer: comparison with standard intravenous carboplatin and paclitaxel. Gynecol Oncol. 2006 Oct;103(1):1-6.
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term Randomized Controlled Trials as Topic

Randomized Controlled Trials as Topic pathology Female drug therapy surgery therapeutic use Male Aged Middle Aged Phase III Clinical Trials as Topic Antineoplastic Combined Chemotherapy Protocols Neoplasm Staging Prognosis 80 and over Aged Adult adverse effects Ovarian Neoplasms Disease-Free Survival Adjuvant Chemotherapy Treatment Outcome administration & dosage Cohort Studies Neoplasm Metastasis methods Phase II Clinical Trials as Topic Antineoplastic Agents Survival Rate metabolism Time Factors Combined Modality Therapy Proportional Hazards Models Survival Analysis United States Monoclonal Antibodies Prostatic Neoplasms Organoplatinum Compounds Cisplatin Predictive Value of Tests Neoplasms Research Design diagnosis mortality Retrospective Studies Neoadjuvant Therapy TOR Serine-Threonine Kinases partial nephrectomy 3-Ring Heterocyclic Compounds Head and Neck Neoplasms Triple Negative Breast Neoplasms psychology Urinary Bladder Neoplasms Illness Behavior mediation Kidney Neoplasms radical nephrectomy Sulfones Perioperative Care Adolescent Geriatric Assessment Nomograms administration & Mental Health Proto-Oncogene Proteins c-akt Kaplan-Meier Estimate Intravenous Infusions outcomes Local recurrence Parenteral Infusions Androgen Antagonists Cytoreduction Surgical Procedures Pain Perception Arthralgia radiotherapy Mastectomy Catastrophization Carboplatin Nephrectomy Kallikreins Melanoma Squamous Cell Carcinoma Biopsy technique Skin Neoplasms pharmacokinetics Age Factors Chemoradiotherapy Biopsy Reproducibility of Results Oropharyngeal Neoplasms United States Food and Drug Administration Health Status Tumor-Infiltrating Lymphocytes blood Patient Reported Outcome Measures Replacement Arthroplasty-Knee principal stratification Neoplasm Invasiveness Pain Measurement Biological Tumor Markers Excision causal inference Notch Receptors Drug Approval Pain Threshold Prostate-Specific Antigen Breast Neoplasms Hormone-Dependent Neoplasms IGF Type 1 Receptor Local Neoplasm Recurrence Organ Sparing Treatments Knee Osteoarthritis Statistical Models antagonists & inhibitors Carcinoma Multicenter Studies as Topic Walk Test Clinical Trials as Topic Factual Databases Tissue Distribution Tumor Biomarkers dosage Propionates Cross-Sectional Studies Benzene Derivatives Young Adult Docetaxel Follow-Up Studies Urothelium Paclitaxel therapy smoking cessation interventions analogs & derivatives Causality analysis Psychological Adaptation Sirolimus physiopathology Colonic Neoplasms Sample Size
Last updated on Monday, November 04, 2019